293 related articles for article (PubMed ID: 26458823)
21. Genetic variants in one-carbon metabolism genes and breast cancer risk in European American and African American women.
Gong Z; Yao S; Zirpoli G; David Cheng TY; Roberts M; Khoury T; Ciupak G; Davis W; Pawlish K; Jandorf L; Bovbjerg DH; Bandera EV; Ambrosone CB
Int J Cancer; 2015 Aug; 137(3):666-77. PubMed ID: 25598430
[TBL] [Abstract][Full Text] [Related]
22. A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium.
Palmer JR; Ambrosone CB; Olshan AF
Cancer Causes Control; 2014 Mar; 25(3):309-19. PubMed ID: 24343304
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
24. Frequency of breast cancer subtypes among African American women in the AMBER consortium.
Allott EH; Geradts J; Cohen SM; Khoury T; Zirpoli GR; Bshara W; Davis W; Omilian A; Nair P; Ondracek RP; Cheng TD; Miller CR; Hwang H; Thorne LB; O'Connor S; Bethea TN; Bell ME; Hu Z; Li Y; Kirk EL; Sun X; Ruiz-Narvaez EA; Perou CM; Palmer JR; Olshan AF; Ambrosone CB; Troester MA
Breast Cancer Res; 2018 Feb; 20(1):12. PubMed ID: 29409530
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer subtypes and previously established genetic risk factors: a bayesian approach.
O'Brien KM; Cole SR; Engel LS; Bensen JT; Poole C; Herring AH; Millikan RC
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):84-97. PubMed ID: 24177593
[TBL] [Abstract][Full Text] [Related]
26. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
Haiman CA; Garcia RR; Hsu C; Xia L; Ha H; Sheng X; Le Marchand L; Kolonel LN; Henderson BE; Stallcup MR; Greene GL; Press MF
BMC Cancer; 2009 Jan; 9():43. PubMed ID: 19183483
[TBL] [Abstract][Full Text] [Related]
27. Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.
Coignet MV; Zirpoli GR; Roberts MR; Khoury T; Bandera EV; Zhu Q; Yao S
PLoS One; 2017; 12(10):e0187205. PubMed ID: 29073238
[TBL] [Abstract][Full Text] [Related]
28. mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women's circle of health study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Gong Z; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Breast Cancer Res Treat; 2023 May; 199(1):137-146. PubMed ID: 36882608
[TBL] [Abstract][Full Text] [Related]
29. Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS).
Gong Z; Quan L; Yao S; Zirpoli G; Bandera EV; Roberts M; Coignet JG; Cabasag C; Sucheston L; Hwang H; Ciupak G; Davis W; Pawlish K; Jandorf L; Bovbjerg DH; Ambrosone CB; Hong CC
PLoS One; 2013; 8(8):e72619. PubMed ID: 23991131
[TBL] [Abstract][Full Text] [Related]
30. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
Haiman CA; Chen GK; Vachon CM; Canzian F; Dunning A; Millikan RC; Wang X; Ademuyiwa F; Ahmed S; Ambrosone CB; Baglietto L; Balleine R; Bandera EV; Beckmann MW; Berg CD; Bernstein L; Blomqvist C; Blot WJ; Brauch H; Buring JE; Carey LA; Carpenter JE; Chang-Claude J; Chanock SJ; Chasman DI; Clarke CL; Cox A; Cross SS; Deming SL; Diasio RB; Dimopoulos AM; Driver WR; Dünnebier T; Durcan L; Eccles D; Edlund CK; Ekici AB; Fasching PA; Feigelson HS; Flesch-Janys D; Fostira F; Försti A; Fountzilas G; Gerty SM; ; Giles GG; Godwin AK; Goodfellow P; Graham N; Greco D; Hamann U; Hankinson SE; Hartmann A; Hein R; Heinz J; Holbrook A; Hoover RN; Hu JJ; Hunter DJ; Ingles SA; Irwanto A; Ivanovich J; John EM; Johnson N; Jukkola-Vuorinen A; Kaaks R; Ko YD; Kolonel LN; Konstantopoulou I; Kosma VM; Kulkarni S; Lambrechts D; Lee AM; Marchand LL; Lesnick T; Liu J; Lindstrom S; Mannermaa A; Margolin S; Martin NG; Miron P; Montgomery GW; Nevanlinna H; Nickels S; Nyante S; Olswold C; Palmer J; Pathak H; Pectasides D; Perou CM; Peto J; Pharoah PD; Pooler LC; Press MF; Pylkäs K; Rebbeck TR; Rodriguez-Gil JL; Rosenberg L; Ross E; Rüdiger T; Silva Idos S; Sawyer E; Schmidt MK; Schulz-Wendtland R; Schumacher F; Severi G; Sheng X; Signorello LB; Sinn HP; Stevens KN; Southey MC; Tapper WJ; Tomlinson I; Hogervorst FB; Wauters E; Weaver J; Wildiers H; Winqvist R; Van Den Berg D; Wan P; Xia LY; Yannoukakos D; Zheng W; Ziegler RG; Siddiq A; Slager SL; Stram DO; Easton D; Kraft P; Henderson BE; Couch FJ
Nat Genet; 2011 Oct; 43(12):1210-4. PubMed ID: 22037553
[TBL] [Abstract][Full Text] [Related]
31. mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women's Circle of Health Study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Cancer Causes Control; 2023 May; 34(5):431-447. PubMed ID: 36790512
[TBL] [Abstract][Full Text] [Related]
32. Associations between estrogen receptor-negative breast cancer and timing of reproductive events differ between African American and European American women.
Ambrosone CB; Zirpoli GR; Bovbjerg DH; Shankar J; Hong CC; McCann SE; Ruszczyk M; Khoury T; Yao S; Ciupak GL; Jandorf L; Pawlish KS; Bandera EV
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1115-20. PubMed ID: 24718280
[TBL] [Abstract][Full Text] [Related]
33. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
[TBL] [Abstract][Full Text] [Related]
34. Single-nucleotide polymorphisms in DNA bypass polymerase genes and association with breast cancer and breast cancer subtypes among African Americans and Whites.
Family L; Bensen JT; Troester MA; Wu MC; Anders CK; Olshan AF
Breast Cancer Res Treat; 2015 Jan; 149(1):181-90. PubMed ID: 25417172
[TBL] [Abstract][Full Text] [Related]
35. An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
Zhu B; Mukherjee A; Machiela MJ; Song L; Hua X; Shi J; Garcia-Closas M; Chanock SJ; Chatterjee N
Br J Cancer; 2016 Sep; 115(6):752-60. PubMed ID: 27467053
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women.
Lin J; Zee RY; Liu KY; Zhang SM; Lee IM; Manson JE; Giovannucci E; Buring JE; Cook NR
Cancer Causes Control; 2010 Jun; 21(6):897-908. PubMed ID: 20148360
[TBL] [Abstract][Full Text] [Related]
37. Genetic variants in sex hormone pathways and the risk of type 2 diabetes among African American, Hispanic American, and European American postmenopausal women in the US.
Goto A; Chen BH; Chan KK; Lee C; Nelson SC; Crenshaw A; Bookman E; Margolis KL; Sale MM; ; Ng MCY; Reiner AP; Liu S
J Diabetes; 2018 Jun; 10(6):524-533. PubMed ID: 29417738
[TBL] [Abstract][Full Text] [Related]
38. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract][Full Text] [Related]
39. Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.
Ghali RM; Al-Mutawa MA; Ebrahim BH; Jrah HH; Zaied S; Bhiri H; Hmila F; Mahjoub T; Almawi WY
Pathol Oncol Res; 2020 Jan; 26(1):141-147. PubMed ID: 29302853
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women.
Ruiz-Narváez EA; Rosenberg L; Cozier YC; Cupples LA; Adams-Campbell LL; Palmer JR
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1320-7. PubMed ID: 20406955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
